Yongxin Huarui Cultural Development Co., Ltd. won a bid to acquire 20.53% stake in Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHSE:600671) from Zhejiang Qingfeng Original Culture Co., Ltd. for approximately CNY 450 million on September 18, 2020. Yongxin Huarui obtained the 25 million shares, accounting for 20.53% of the company’s total capital. On November 13, 2020, Yongxin Huarui received the auction execution ruling issued by the Intermediate People's Court of Suzhou City. Yongxin Huarui Cultural Development Co., Ltd. completed the acquisition of 20.53% stake in Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHSE:600671) from Zhejiang Qingfeng Original Culture Co., Ltd. on December 17, 2020.